glp-1 cirrhosis The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis GLP-1 Receptor Agonists in Non-Alcoholic

Oct 2023;5(10):100704

Monitoring strategies should be individualized based on patient risk factors and align with FDA prescribing information, which recommends monitoring heart rate at regular intervals for some GLP-1 receptor agonists

The hypothalamus, particularly the arcuate nucleus, contains GLP-1 receptors that modulate hunger and satiety signals

Some users self-report increased hunger

Comfort, convenience, and consistency should guide injection site selection, provided injections are performed correctly and sites are rotated

2016 SUSTAIN-6 reported a reduction in major adverse cardiovascular events among high-risk participants, expanding research interest beyond glucose and weight